Log In
Print this Print this

Japanese cedar tree pollen Allergy Immunotherapy Tablet (AIT) (TO-206)

  Manage Alerts
Collapse Summary General Information
Company Torii Pharmaceutical Co. Ltd.
DescriptionTablet-based sublingual allergen immunotherapy
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II/III
Standard IndicationRhinitis
Indication DetailsTreat Japanese cedar tree pollen-induced allergic rhinitis
Regulatory Designation
PartnerALK-Abello A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today